share_log

Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticals

Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticals

坎托·菲茨杰拉德重申增持Agios Pharmicals
Moomoo 24/7 ·  04/09 08:27

Cantor Fitzgerald analyst Eric Schmidt reiterates Agios Pharmaceuticals (NASDAQ:AGIO) with a Overweight.

坎托·菲茨杰拉德分析师埃里克·施密特重申Agios Pharmicals(纳斯达克股票代码:AGIO)增持。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发